154 related articles for article (PubMed ID: 26298467)
1. Prognostic value of thyroid-stimulating hormone within reference range in patients with coronary artery disease.
Ndrepepa G; Braun S; Mayer K; Cassese S; Fusaro M; Byrne RA; Hoppmann P; Schunkert H; Laugwitz KL; Kastrati A
Metabolism; 2015 Oct; 64(10):1308-15. PubMed ID: 26298467
[TBL] [Abstract][Full Text] [Related]
2. Gamma-glutamyl transferase and prognosis in patients with coronary artery disease.
Ndrepepa G; Braun S; Schunkert H; Laugwitz KL; Kastrati A
Clin Chim Acta; 2016 Jan; 452():155-60. PubMed ID: 26581592
[TBL] [Abstract][Full Text] [Related]
3. Alkaline phosphatase and prognosis in patients with coronary artery disease.
Ndrepepa G; Xhepa E; Braun S; Cassese S; Fusaro M; Schunkert H; Kastrati A
Eur J Clin Invest; 2017 May; 47(5):378-387. PubMed ID: 28369867
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein and prognosis in women and men with coronary artery disease after percutaneous coronary intervention.
Ndrepepa G; Braun S; Cassese S; Fusaro M; King L; Kastrati A; Schmidt R
Cardiovasc Revasc Med; 2013; 14(5):264-9. PubMed ID: 23969223
[TBL] [Abstract][Full Text] [Related]
5. Association of uric acid with mortality in patients with stable coronary artery disease.
Ndrepepa G; Braun S; King L; Hadamitzky M; Haase HU; Birkmeier KA; Schömig A; Kastrati A
Metabolism; 2012 Dec; 61(12):1780-6. PubMed ID: 22749121
[TBL] [Abstract][Full Text] [Related]
6. Comparative prognostic value of low-density lipoprotein cholesterol and C-reactive protein in patients with stable coronary artery disease treated with percutaneous coronary intervention and chronic statin therapy.
Ndrepepa G; Braun S; Tada T; Guerra E; Schunkert H; Laugwitz KL; Kastrati A
Cardiovasc Revasc Med; 2014 Apr; 15(3):131-6. PubMed ID: 24630704
[TBL] [Abstract][Full Text] [Related]
7. Procedure-related bleeding in elective percutaneous coronary interventions.
Ndrepepa G; Stephan T; Fiedler KA; Guerra E; Kufner S; Kastrati A
Eur J Clin Invest; 2015 Mar; 45(3):263-73. PubMed ID: 25645583
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of gamma-glutamyl transferase in patients with diabetes mellitus and coronary artery disease.
Ndrepepa G; Colleran R; Luttert A; Braun S; Cassese S; Kufner S; Hieber J; Fusaro M; Laugwitz KL; Schunkert H; Kastrati A
Clin Biochem; 2016 Oct; 49(15):1127-1132. PubMed ID: 27220059
[TBL] [Abstract][Full Text] [Related]
9. Serum alkaline phosphatase is a predictor of mortality, myocardial infarction, or stent thrombosis after implantation of coronary drug-eluting stent.
Park JB; Kang DY; Yang HM; Cho HJ; Park KW; Lee HY; Kang HJ; Koo BK; Kim HS
Eur Heart J; 2013 Mar; 34(12):920-31. PubMed ID: 23242189
[TBL] [Abstract][Full Text] [Related]
10. Inverse association of alanine aminotransferase within normal range with prognosis in patients with coronary artery disease.
Ndrepepa G; Holdenrieder S; Colleran R; Cassese S; Xhepa E; Fusaro M; Laugwitz KL; Schunkert H; Kastrati A
Clin Chim Acta; 2019 Sep; 496():55-61. PubMed ID: 31254501
[TBL] [Abstract][Full Text] [Related]
11. Postprocedural high-sensitivity troponin T and prognosis in patients with non-ST-segment elevation myocardial infarction treated with early percutaneous coronary intervention.
Harada Y; Koskinas KC; Ndrepepa G; Räber L; Braun S; Zanchin T; Kufner S; Hunziker L; Byrne RA; Heg D; Kastrati A; Windecker S
Cardiovasc Revasc Med; 2018 Jul; 19(5 Pt A):480-486. PubMed ID: 29292015
[TBL] [Abstract][Full Text] [Related]
12. Acute coronary syndrome and stable coronary artery disease: are they so different? Long-term outcomes in a contemporary PCI cohort.
Alcock RF; Yong AS; Ng AC; Chow V; Cheruvu C; Aliprandi-Costa B; Lowe HC; Kritharides L; Brieger DB
Int J Cardiol; 2013 Aug; 167(4):1343-6. PubMed ID: 22534045
[TBL] [Abstract][Full Text] [Related]
13. An elevated monocyte-to-high-density lipoprotein-cholesterol ratio is associated with mortality in patients with coronary artery disease who have undergone PCI.
Zhang DP; Baituola G; Wu TT; Chen Y; Hou XG; Yang Y; Pan Y; Ma X; Zheng YY
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32766711
[TBL] [Abstract][Full Text] [Related]
14. Correlates of poor outcome among patients with bleeding after coronary interventions.
Ndrepepa G; Guerra E; Schulz S; Hoppmann P; Laugwitz KL; Kastrati A
Coron Artery Dis; 2014 Sep; 25(6):456-62. PubMed ID: 24801558
[TBL] [Abstract][Full Text] [Related]
15. The relationship between thyroid stimulating hormone within the reference range and coronary artery disease: impact of age.
Yang L; Zou J; Zhang M; Xu H; Qi W; Gao L; Zhao J
Endocr J; 2013; 60(6):773-9. PubMed ID: 23470525
[TBL] [Abstract][Full Text] [Related]
16. Total leucocyte count, but not C-reactive protein, predicts 1-year mortality in patients with acute coronary syndromes treated with percutaneous coronary intervention.
Ndrepepa G; Braun S; Iijima R; Keta D; Byrne RA; Schulz S; Mehilli J; Schömig A; Kastrati A
Clin Sci (Lond); 2009 Apr; 116(8):651-8. PubMed ID: 18851714
[TBL] [Abstract][Full Text] [Related]
17. Relationship between platelet count and 30-day clinical outcomes after percutaneous coronary interventions. Pooled analysis of four ISAR trials.
Iijima R; Ndrepepa G; Mehilli J; Bruskina O; Schulz S; Schömig A; Kastrati A
Thromb Haemost; 2007 Oct; 98(4):852-7. PubMed ID: 17938811
[TBL] [Abstract][Full Text] [Related]
18. Impact of inhospital stent thrombosis and cerebrovascular accidents on long-term prognosis after percutaneous coronary intervention.
Guerra E; Ndrepepa G; Schulz S; Byrne R; Hoppmann P; Kufner S; Ibrahim T; Tada T; Schunkert H; Laugwitz KL; Kastrati A
Am Heart J; 2014 Dec; 168(6):862-8.e1. PubMed ID: 25458649
[TBL] [Abstract][Full Text] [Related]
19. Differential prognostic impact of high on-treatment platelet reactivity among patients with acute coronary syndromes versus stable coronary artery disease undergoing percutaneous coronary intervention.
Park DW; Ahn JM; Song HG; Lee JY; Kim WJ; Kang SJ; Yun SC; Lee SW; Kim YH; Lee CW; Park SW; Park SJ
Am Heart J; 2013 Jan; 165(1):34-42.e1. PubMed ID: 23237131
[TBL] [Abstract][Full Text] [Related]
20. Aspartate aminotransferase and mortality in patients with ischemic heart disease.
Ndrepepa G; Holdenrieder S; Cassese S; Xhepa E; Fusaro M; Laugwitz KL; Schunkert H; Kastrati A
Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2335-2342. PubMed ID: 32917497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
